DK167353B1 - Phenylethanolaminotetraliner og farmaceutisk acceptable salte deraf og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende dem - Google Patents

Phenylethanolaminotetraliner og farmaceutisk acceptable salte deraf og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende dem Download PDF

Info

Publication number
DK167353B1
DK167353B1 DK328586A DK328586A DK167353B1 DK 167353 B1 DK167353 B1 DK 167353B1 DK 328586 A DK328586 A DK 328586A DK 328586 A DK328586 A DK 328586A DK 167353 B1 DK167353 B1 DK 167353B1
Authority
DK
Denmark
Prior art keywords
group
optionally
amino
formula
compound
Prior art date
Application number
DK328586A
Other languages
Danish (da)
English (en)
Other versions
DK328586A (da
DK328586D0 (da
Inventor
Roberto Cecchi
Robert Boigegrain
Alberto Bianchetti
Elena Poggesi
Tiziano Croci
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8510559A external-priority patent/FR2584712B1/fr
Priority claimed from FR8606626A external-priority patent/FR2598410B1/fr
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of DK328586D0 publication Critical patent/DK328586D0/da
Publication of DK328586A publication Critical patent/DK328586A/da
Application granted granted Critical
Publication of DK167353B1 publication Critical patent/DK167353B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/64—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK328586A 1985-07-10 1986-07-10 Phenylethanolaminotetraliner og farmaceutisk acceptable salte deraf og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende dem DK167353B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR8510559A FR2584712B1 (fr) 1985-07-10 1985-07-10 Phenylethanolamines a activite lipolytique, un procede pour leur preparation et compositions pharmaceutiques en contenant
FR8510559 1985-07-10
FR8606626 1986-05-07
FR8606626A FR2598410B1 (fr) 1986-05-07 1986-05-07 Phenylethanolamines optiquement actives, un procede pour leur preparation et compositions pharmaceutiques en contenant

Publications (3)

Publication Number Publication Date
DK328586D0 DK328586D0 (da) 1986-07-10
DK328586A DK328586A (da) 1987-01-11
DK167353B1 true DK167353B1 (da) 1993-10-18

Family

ID=26224609

Family Applications (1)

Application Number Title Priority Date Filing Date
DK328586A DK167353B1 (da) 1985-07-10 1986-07-10 Phenylethanolaminotetraliner og farmaceutisk acceptable salte deraf og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende dem

Country Status (18)

Country Link
US (1) US4707497A (de)
EP (1) EP0211721B1 (de)
JP (1) JPS6263549A (de)
KR (1) KR940007739B1 (de)
AR (1) AR241014A1 (de)
AT (1) ATE46900T1 (de)
AU (1) AU596976B2 (de)
CA (1) CA1260493A (de)
DE (1) DE3666036D1 (de)
DK (1) DK167353B1 (de)
ES (1) ES2002717A6 (de)
FI (1) FI85692C (de)
GR (1) GR861764B (de)
IE (1) IE59399B1 (de)
IL (1) IL79323A (de)
NO (1) NO165190C (de)
NZ (1) NZ216793A (de)
PT (1) PT82930B (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3623941A1 (de) * 1986-07-16 1988-01-28 Bayer Ag Substituierte amino-5,6,7,8-tetrahydronaphthyl-oxyessigsaeuren, verfahren zu deren herstellung sowie die verwendung als arzneimittel
US5153225A (en) * 1986-12-10 1992-10-06 Bayer Aktiengesellschaft Substituted basic 2-aminotetralin in pharmaceuticals
DE3718317A1 (de) * 1986-12-10 1988-06-16 Bayer Ag Substituierte basische 2-aminotetraline
IT1199339B (it) * 1986-12-23 1988-12-30 Sigma Tau Ind Farmaceuti N-alchil derivati della 2-ammino-6,7-dimetossi tetralina,procedimenti per la loro preparazione e composizioni farmaceutiche ad attivita'an tiipertensiva che li contengono
FR2629453B1 (fr) * 1988-03-30 1990-10-05 Midy Spa Procede pour la preparation de phenylethanolaminotetralines
US5235103A (en) * 1987-08-12 1993-08-10 Sanofi Process for the preparation of phenylethanolaminotetralins
FR2619378B1 (fr) * 1987-08-12 1989-12-15 Midy Spa Procede pour la preparation de phenylethanolaminotetralines
FR2632636B1 (fr) * 1988-06-14 1991-03-22 Midy Spa Procede pour la preparation de phenylethanolaminotetralines
US5198586A (en) * 1987-08-12 1993-03-30 Sanofi Process for the preparation of phenylethanolaminotetralins
ES2067483T3 (es) * 1987-08-12 1995-04-01 Sanofi Sa Procedimiento para la o-alquilacion de n-(hidroxi)aralquilfeniletanolaminas.
FR2632637B1 (fr) * 1988-06-14 1990-10-12 Midy Spa Ethers de la 2-amino-7-hydroxytetraline
FR2619379B1 (fr) * 1987-08-12 1990-01-12 Midy Spa Procede pour la o-alkylation de n-(hydroxy) aralkyl-phenylethanolamines
EP0303545B1 (de) * 1987-08-12 1992-06-17 Elf Sanofi Verfahren zur Herstellung von Phenyläthanolaminotetralinen
FR2619718B1 (fr) * 1987-09-02 1991-07-12 Medibrevex Nouvelles formes galeniques de beta-2-mimetiques pour administration par voie per- et sublinguale
CA1331191C (en) * 1988-03-25 1994-08-02 Bengt Ronny Andersson Therapeutically useful tetralin derivatives
US5202466A (en) * 1988-06-14 1993-04-13 Sanofi 2-amino-7-hydroxytetraline ethers
FR2648042B1 (fr) * 1989-06-13 1994-06-10 Midy Spa Utilisation de phenylethanolaminotetralines pour la preparation de medicaments pour le traitement des affections oculaires
FR2643076B1 (fr) * 1989-02-14 1991-06-21 Midy Spa Carboxyalkyl-ethers de la 2-amino-7-hydroxytetraline
SE8901889D0 (sv) * 1989-05-26 1989-05-26 Astra Ab Novel 8-substituted-2-aminotetralines
IT1230931B (it) * 1989-06-27 1991-11-08 Chiesi Farma Spa Derivati di 2 ammino 1,2,3,4 tetraidronaftalene ad attivita' cardiovascolare, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
FR2653765B1 (fr) * 1989-10-31 1993-08-06 Midy Spa Procede pour la preparation enantioselective de 2-aminotetralines.
FR2656607B1 (fr) * 1989-12-29 1994-03-11 Midy Spa Phenylethanolaminomethyltetralines.
IE65511B1 (en) * 1989-12-29 1995-11-01 Sanofi Sa New phenylethanolaminomethyltetralins
FR2669821A1 (fr) * 1990-12-04 1992-06-05 Sanofi Sa Utilisation de phenylethanolaminotetralines pour la preparation de medicaments destines au traitement de la depression.
EP0499755A1 (de) * 1991-02-18 1992-08-26 MIDY S.p.A. Phenylethanolaminotetraline, Verfahren zu deren Herstellung, Zwischenprodukte davon und diese enthaltende pharmazeutische Zusammensetzungen
GB9107827D0 (en) * 1991-04-12 1991-05-29 Fujisawa Pharmaceutical Co New ethanolamine derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
IL104567A (en) * 1992-02-03 1997-03-18 Fujisawa Pharmaceutical Co Ethanolamine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
SG47557A1 (en) * 1993-01-29 1998-04-17 American Cyanamid Co Aminocycloalkanobenzodioxoles as beta-3 selective adrenergic agents
EP0627407A1 (de) * 1993-05-28 1994-12-07 MIDY S.p.A. (7S)-7-(2R)-2(3-Chlorophenyl)-2-hydroxethylamino-5,6,7,8-Tetrahydronaphthalen-2-yloxy-Essigsäure, ihre pharmazeutisch akzeptablen Salze, mit Beta-3-adrenergischer agonistischer Aktivität und diese enthaltende pharmazeutische Zusammensetzung
US5578638A (en) * 1993-11-05 1996-11-26 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
US5563171A (en) * 1993-11-05 1996-10-08 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists
US5776983A (en) * 1993-12-21 1998-07-07 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
US5491134A (en) * 1994-09-16 1996-02-13 Bristol-Myers Squibb Company Sulfonic, phosphonic or phosphiniic acid β3 agonist derivatives
US5541204A (en) * 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists
US6197993B1 (en) 1996-07-02 2001-03-06 Ono Pharmaceutical Co., Ltd. Naphthyloxyacetic acid derivatives and a pharmaceutical composition comprising them as an active ingredient
WO1997005091A1 (en) * 1995-07-26 1997-02-13 Ono Pharmaceutical Co., Ltd. Naphthyloxyacetic acid derivatives and drugs comprising the same as active ingredients
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
US5770615A (en) * 1996-04-04 1998-06-23 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
DE69711519T2 (de) 1996-09-05 2002-10-31 Eli Lilly And Co., Indianapolis Carbazolanaloge als selektive beta3-adrenergische Agonisten
US5808080A (en) * 1996-09-05 1998-09-15 Eli Lilly And Company Selective β3 adrenergic agonists
FR2758723B1 (fr) * 1997-01-28 1999-04-23 Sanofi Sa Utilisation des antagonistes des recepteurs aux cannabinoides centraux pour la preparation de medicaments
CO5011072A1 (es) * 1997-12-05 2001-02-28 Lilly Co Eli Etanolaminas pirazinil substituidas como agfonistas de los receptores
EP1070046A1 (de) * 1998-04-06 2001-01-24 Fujisawa Pharmaceutical Co., Ltd. Propanolaminderivate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK254975A (da) * 1974-06-12 1975-12-13 Takeda Chemical Industries Ltd Fremgangsmade til fremstilling af aminotetralolforbindelser
DE2803582A1 (de) * 1978-01-27 1979-08-02 Sandoz Ag Neue tetralinderivate, ihre herstellung und verwendung
ATE6500T1 (de) * 1980-01-30 1984-03-15 American Hospital Supply Corporation 2-alpha-methyl-dopaminimino-6,7-dihydroxy-1,2,3 4-tetrahydronaphthalin, seine salze, und verfahren zu dessen herstellung.

Also Published As

Publication number Publication date
FI85692B (fi) 1992-02-14
PT82930A (fr) 1986-08-01
NO862773L (no) 1987-01-12
AR241014A1 (es) 1991-04-30
DK328586A (da) 1987-01-11
NZ216793A (en) 1990-05-28
JP5071581B2 (de) 1993-10-07
GR861764B (en) 1986-11-10
IL79323A0 (en) 1986-10-31
EP0211721B1 (de) 1989-10-04
FI862907L (fi) 1987-01-11
NO862773D0 (no) 1986-07-09
CA1260493A (en) 1989-09-26
KR940007739B1 (ko) 1994-08-24
IE861820L (en) 1987-01-10
IL79323A (en) 1990-03-19
AU596976B2 (en) 1990-05-24
KR870001151A (ko) 1987-03-11
DK328586D0 (da) 1986-07-10
AU5988986A (en) 1987-01-15
US4707497A (en) 1987-11-17
NO165190C (no) 1991-01-09
ATE46900T1 (de) 1989-10-15
DE3666036D1 (en) 1989-11-09
NO165190B (no) 1990-10-01
PT82930B (pt) 1989-01-30
EP0211721A1 (de) 1987-02-25
FI862907A0 (fi) 1986-07-10
AR241014A2 (es) 1991-04-30
JPS6263549A (ja) 1987-03-20
FI85692C (fi) 1992-05-25
ES2002717A6 (es) 1992-04-16
IE59399B1 (en) 1994-02-23

Similar Documents

Publication Publication Date Title
US4707497A (en) Phenylethanolaminotetralines, a process for their preparation and pharmaceutical compositions containing them
KR100430022B1 (ko) 신경장애의치료에유용한수용체-작동칼슘채널의신규부위에서활성인화합물
WO1981003491A1 (en) Therapeutically useful tetralin derivatives
JP4819280B2 (ja) カテコールアミンのプロドラッグとしてのフェニルエチルアミンおよび縮合環のヴァリアント（ｖａｒｉａｎｔ）、ならびにその使用
KR900001511B1 (ko) 카테콜 유도체 및 그것을 함유하는 중추신경계 퇴행성질환의 진행방지 및 치료제
RU2760558C2 (ru) Целевой лекарственный препарат и новые композиции, комбинации на его основе и способы их применения
JPH0419221B2 (de)
EP0284621A1 (de) Psychostimulierendes mittel.
US9687459B2 (en) Aminocyclobutane derivatives, method for preparing same and the use thereof as drugs
EP1096926B1 (de) Verfahren und verbindungen zur behandlung der depression
CS225850B2 (en) Process for preparing new r,r-n-(2-phenyl-2-hydroxyethyl)-1-methyl-3-phenylpropylamines
JPH0770013A (ja) β３ −アドレナリン作動薬として作用する｛（７Ｓ）−７−［（２Ｒ）−２−（３−クロロフェニル）−２−ヒドロキシエチルアミノ］−５，６，７，８−テトラヒドロナフタレン−２−イルオキシ）酢酸及びその薬学的に許容されうる塩、並びにそれらが存在する薬学的組成物及び研究室用試薬
NO823344L (no) 3-fenyl-1-indanaminer.
JPH08333315A (ja) エチルアミドフルオレン及びその改良された製造方法
FR2653999A1 (fr) Nouveaux derives de la morpholine, leur procede de preparation et les compositions pharmaceutiques les renfermant.
US4395410A (en) Quaternary ammonium antiarrhythmic drugs
FR2598410A1 (fr) Phenylethanolamines optiquement actives, un procede pour leur preparation et compositions pharmaceutiques en contenant
HK1240927B (zh) 氨基环丁烷衍生物、其制备方法及其用作药物的用途
FR2584712A1 (fr) Phenylethanolamines a activite lipolytique, un procede pour leur preparation et compositions pharmaceutiques en contenant
HK1240927A1 (en) Aminocyclobutane derivatives, method for preparing same and the use thereof as drugs
AU7179781A (en) Therapeutically useful tetralin derivatives
HK1212968B (en) Aminocyclobutane derivatives, method for preparing same and the use thereof as drugs
HK1088009B (en) Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use
EP1790337A2 (de) Verfahren und Verbindungen zur Behandlung von Depressionen und anderen Erkrankungen

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed